5-[3-(2-
was attached to the caudal portion of the epicardium at a distance of 1.5cm from the stimulating electrode. The atrial rate (sinus cycle length; SCL) was measured with a cardiotachometer triggered by a signal from the atrial depolarization of the electrogram. Developed tension was isometrically measured with a force displacement transducer (Nihon Kohden AP620G) connected to a part of the atrial muscle with a silk thread. Sinoatrial conduction time (SACT) was estimated using constant atrial pacing consisting of a train of 8 cycles at a rate 10 beats/min faster than the spontaneous rate (Narula et al, 1978 ).6) Kobayashi et al7) reported that there was a good correlation between the SACT measured by the continuous atrial pacing method and by the premature atrial stimulation method (Strauss et al, 1973) 8) using the isolated dog atrial preparation. SACT was calculated by subtracting the control SCL from the first atrial return cycle. This interval represents the total conduction time into and out of the sinus node. Pacing stimuli were provided by an electric stimulator (Nihon Kohden SEN-7130) with a strength of approximately twice threshold voltage and a duration of 2msec. SACT was digitized by a pulse counter (Nihon Kohden ET612J) and a printer (Citizen CBM Co.). This procedure was repeated 5 times and SACT was gained using 20% trimmed mean.
The donor dogs, weighing 12-25kg, were anesthetized with 30mg/kg of sodium pentobarbital i.v. and artificially ventilated with room air by use of a Harvard respirator. Sodium heparin, 500 units/kg, was administered intravenously at the beginning of the perfusion and 200 units/kg added at hourly intervals. Details of the preparation were previously reported. 4),5),7),9), 10) Drugs used in this study were 2-isopropyl-5-[3-(2-methoxyphenoxy)propylamino]-2-(3,4,5-trimethoxyphenyl)valeronitrile fumarate ( Fig.1 ) (HV-525, provided by Hokuriku Seiyaku Co., Ltd.), norepinephrine hydrochloride (Sankyo), propranolol hydrochloride (Sumitomo Chemicals), verapamil hy- pressure (SBP) and heart rate (HR) in a donor dog (A), and on atrial rate (AR) and developed tension (DT) in an isolated atrium (B), when administered intravenously to a donor dog. Fig.3 . Effects of 1mg/kg of HV-525 on systemic blood pressure (SBP) and heart rate (HR) in a donor dog (A), and developed tension (DT) in an isolated atrium (B) electrically paced (2.5Hz, 2 volts, 5msec duration). a depressor response with slight sinus bradycardia or tachycardia was induced in the intact dog and negative chronotropic and inotropic responses in the isolated atrium were produced in a dose-related mariner. Fig.2 shows an example of a tracing of cardiovascular responses of a donor dog and an isolated atrium.
In a paced isolated atrial preparation, the intravenous administration of 1mg/kg of HV-525 to the donor dog caused a depressor response with bradycardia in the intact animal and a negative inotropic response in the isolated atrium as shown in Fig.3 .
A relatively small dose of 0.3mg/kg, i.v., of HV-525 induced a clear depressor response in donor dogs and a slight decrease in developed tension without any changes in atrial rate 
DISCUSSION
In the present study, we examined the cardiovascular effects of a newly synthesized compound, 2-isopropyl-5-[3-(2-methoxyphenoxy)propylamino]-2-(3,4,5-trimethoxyphenyl)valeronitrile fumarate (HV-525) in cross-perfused atrial muscle preparations which were perfused with donor's arterial blood. Intravenous HV-525 usually induced a hypotensive effect with sinus bradycardia or tachycardia in intact dogs and slight negative chronotropic and inotropic effects in isolated atria. These response patterns were similar to those to verapamil in the same type of experiments.10) Intraarterial administration of HV-525 usually induced negative chronotropic and inotropic effects, indicating that verapamil was roughly 10-30 times more potent than Jpn phenytoin>disopyramide>procainamidequinidine.
Occasionally, HV-525, induced positive chronotropic and inotropic effects when injected directly into the sinus node artery.
Recently, Thomas et al16) reported that minor changes in the nifedipine molecule result in drugs that have pharmacological properties diametrically opposite to those of the classical calcium channel blockers of the dihydropyridine type. BAY K 8644 (a dihydropyridine derivative), the prototype of these new compounds, turned out to have positive inotropic and vasoconstricting effects by increasing the transmembrane calcium current through the slow channel.17) HV-525 used in this study, a phenoxyalkylamine derivative, may both inhibit and promote transmembrane calcium influx. However, as HV-525-induced positive effects were not usual, more precise experiments are needed to analyze its ability to promote calcium influx by verapamil derivatives.
HV-525 did not change the positive staircase to a negative staircase phenomenon, differing in this respect from verapamil. This means that HV-525 may have a different pharmacologic action on the heart from that of verapamil.
A large amount of HV-525 slightly inhibited the norepinephrineinduced positive chronotropic and inotropic effects, although a small dose of propranolol completely blocked the norepinephrine-induced effects. Thus, HV-525 did not have adrenergic beta-receptor blocking properties.
From these results, it is concluded that HV-525 has slight, direct negative chronotropic and predominant negative inotropic activity on the heart along, with marked depressor action.
